Astrocyte Pharmaceuticals Inc.
A Novel Approach to Neuroprotection
Astrocyte Pharmaceuticals is a preclinical neuroscience drug development company with a novel small molecule drug for the treatment of stroke, traumatic brain injuries and concussions. The company has demonstrated significant neuroprotective efficacy in mouse, rat, pig, and non-human primate models, with acute treatment administered as late as 24 hours post injury. The company has raised ~$10M in public and private investment.